Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting of the tumor immune microenvironment by metformin
Zihong Wu, Caidie Zhang, Masoud Najafi
Journal of Cell Communication and Signaling (2021) Vol. 16, Iss. 3, pp. 333-348
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

The interactions of docetaxel with tumor microenvironment
Reena Gupta, Mustafa M. Kadhim, Abduladheem Turki Jalil, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110214-110214
Closed Access | Times Cited: 44
Interactions and communications in lung tumor microenvironment: Chemo/radiotherapy resistance mechanisms and therapeutic targets
Feng Yuan, Ying Jiang, Lin Yang, et al.
Journal of drug targeting (2025), pp. 1-33
Closed Access | Times Cited: 2
The interactions of paclitaxel with tumour microenvironment
Ding‐Li Yu, Zhiping Lou, Fengyun Ma, et al.
International Immunopharmacology (2022) Vol. 105, pp. 108555-108555
Closed Access | Times Cited: 67
Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation by Natural Products
Holya A. Lafta, Ali Hamid AbdulHussein, Saif A. J. Al-Shalah, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 12, pp. 1104-1122
Closed Access | Times Cited: 40
Immunoregulation by resveratrol; implications for normal tissue protection and tumour suppression
Armineh Rezagholi Lalani, Fatemeh Fakhari, Shakila Radgoudarzi, et al.
Clinical and Experimental Pharmacology and Physiology (2023) Vol. 50, Iss. 5, pp. 353-368
Closed Access | Times Cited: 29
Targeting oral tumor microenvironment for effective therapy
Hendrik Setia Budi, Bagher Farhood
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 26
Tumor microenvironment remodeling in oral cancer: Application of plant derived-natural products and nanomaterials
Hendrik Setia Budi, Bagher Farhood
Environmental Research (2023) Vol. 233, pp. 116432-116432
Closed Access | Times Cited: 25
Exploring the mystery of tumor metabolism: Warburg effect and mitochondrial metabolism fighting side by side
Yongxin Yu, Yulang Jiang, Christian Glandorff, et al.
Cellular Signalling (2024) Vol. 120, pp. 111239-111239
Closed Access | Times Cited: 16
Metformin‐Mediated Immunosuppressive Microenvironment Remodeling in Combination with Chemotherapy via a Spatial‐Specific Multi‐Responsive Carrier‐Free Self‐Assembled Nanoparticle
Yujun Song, Yufan Du, Chuan Hu, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 25
Closed Access | Times Cited: 11
Quercetin exerts anti-tumor immune mechanism by regulating IL-6/JAK2/STAT3 signaling pathway to deplete Treg cells
Yu‐Pei Liao, Xiaoqing Xie, Chu Zhang, et al.
Toxicon (2024) Vol. 243, pp. 107747-107747
Closed Access | Times Cited: 10
Modulation of the immune system by melatonin; implications for cancer therapy
Masoud Moslehi, Reza Moazamiyanfar, Mohammad Sedigh Dakkali, et al.
International Immunopharmacology (2022) Vol. 108, pp. 108890-108890
Closed Access | Times Cited: 38
Mechanisms of cancer cell killing by metformin: a review on different cell death pathways
Xiaoyu Wu, Wenwen Xu, Xiangkun Huan, et al.
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 1, pp. 197-214
Closed Access | Times Cited: 32
Resveratrol in Cancer Therapy: From Stimulation of Genomic Stability to Adjuvant Cancer Therapy: A Comprehensive Review
Peyman Amini, Reza Moazamiyanfar, Mohammad Sedigh Dakkali, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 23, Iss. 8, pp. 629-648
Closed Access | Times Cited: 32
Apigenin in cancer therapy: Prevention of genomic instability and anticancer mechanisms
Masoud Moslehi, Sepideh Rezaei, Pourya Talebzadeh, et al.
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 50, Iss. 1, pp. 3-18
Closed Access | Times Cited: 31
Targeting anticancer immunity in oral cancer: Drugs, products, and nanoparticles
Liling Qin, Jianan Wu
Environmental Research (2023) Vol. 239, pp. 116751-116751
Closed Access | Times Cited: 20
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Yogita Dhas, Nupur Biswas, M R Divyalakshmi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 7
Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy
Shahram Taeb, Milad Ashrafizadeh, Ali Zarrabi, et al.
Current Cancer Drug Targets (2021) Vol. 22, Iss. 1, pp. 18-30
Closed Access | Times Cited: 36
The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors
Samaneh Mostafavi, Hamidreza Zalpoor, Zuhair Mohammad Hassan
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 25
Mechanisms of cancer cell death induction by triptolide
Ali Hamid AbdulHussein, Muataz Mohammed Al‐Taee, Zahra Abdul Radih, et al.
BioFactors (2023) Vol. 49, Iss. 4, pp. 718-735
Closed Access | Times Cited: 13
Targeting the prostate tumor microenvironment by plant-derived natural products
Jiacheng Wu, Hao Ji, Tiantian Li, et al.
Cellular Signalling (2023) Vol. 115, pp. 111011-111011
Closed Access | Times Cited: 11
The promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapy
Zakia Akter, Narges Salamat, Md. Yousuf Ali, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 10
The diverse effects of cisplatin on tumor microenvironment: Insights and challenges for the delivery of cisplatin by nanoparticles
Xinxin Meng, Feng‐Yun Ma, Dingli Yu
Environmental Research (2023) Vol. 240, pp. 117362-117362
Closed Access | Times Cited: 10
Multifunctional nanodrug for simultaneously combating chemoresistance and immunosuppression in Fusobacterium nucleatum-associated colorectal cancer
Xiaohui Li, Mengdi Wu, Yu Wu, et al.
Acta Biomaterialia (2025)
Closed Access
Boosting Anti-tumour Immunity Using Adjuvant Apigenin
Chuli Xiao, Masoud Najafi, Jun Huang, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 23, Iss. 3, pp. 266-277
Closed Access | Times Cited: 15
An effective treatment approach of liposomally encapsulated metformin in colon cancer
Enis A. Cetin, Olcay Boyacıoğlu, Seda Örenay-Boyacıoğlu
Medical Oncology (2024) Vol. 41, Iss. 4
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top